Head-to-head · computed 2026-08-11
Elevate Health vs Hims & Hers
Elevate Health: Elevate Health sells compounded tirzepatide at $449 a month on its monthly plan or $263 a month on a prepaid 12-week program, with free blood work included and brand-name Zepbound also on the menu; its compounded semaglutide pricing spans a promotional band our desk has not resolved to a rankable maintenance figure. Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
Tirzepatide
| Elevate Health | Hims & Hers | |
|---|---|---|
| All-in maintenance | $449/mo | $548/mo |
| Best plan rate | $263/mo | $548/mo |
| 12-month total | $5,388 | $6,576 |
| Status | Reported · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Elevate Health's $449 a month undercuts Hims & Hers's $548 by $99 a month at the 10 mg/wk maintenance basis — $1,188 across a year. Elevate Health's figure is reported (captured 2026-08-11) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Elevate Health's tirzepatide ladder runs $449 a month billed monthly, and $263 a month on a three-month plan. Hims & Hers's runs $548 a month billed monthly. On the twelve-month basis Elevate Health's $5,388 beats Hims & Hers's $6,576 by $1,188 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Elevate Health | Hims & Hers | |
|---|---|---|
| All-in maintenance | not published | $453/mo |
| Best plan rate | — | $453/mo |
| 12-month total | — | $5,436 |
| Status | Reported · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
Elevate Health does not publish a rankable maintenance-dose figure for semaglutide, so no winner can honestly be declared — a start-only price tells you what month one costs, not what the program costs.
Where the structures genuinely differ
Elevate Health carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On verifiability, Hims & Hers names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Elevate Health's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice. On exit terms, Hims & Hers's structure avoids prepaid lock-in while Elevate Health's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Elevate Health
- MembershipNone
- Dose policyNot stated on captured materials
- CommitmentMonthly, or 12-week prepaid program
- CancellationPer published terms; 12-week program is prepaid — confirm refund terms at checkout
- PharmacyPartner pharmacy (unnamed on captured materials); clinical network via MDIntegra
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
What our desk is watching on each
Elevate Health: Captures are dated (tirzepatide plan structure from a September 2025 consumer walkthrough; injectable band $233–$263 from January 2026 materials) — re-capture flagged. Three structural notes: checkout precedes medical qualification in the published flow (BMI ≥30, or ≥27 with a condition, gates approval after payment); the dispensing pharmacy is unnamed on captured materials, which fails this desk's verification workflow until answered; and the platform sells peptide add-ons (NAD+, glutathione) alongside GLP-1s — read the verification masterclass's add-on cautions before bundling. Not on the FDA's September 2025 warning-letter list per directory review; Trustpilot rating carries a review-solicitation flag.
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Questions people ask
Is Elevate Health or Hims & Hers cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Elevate Health vs Hims & Hers miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Elevate Health and Hims & Hers cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $5,388 at Elevate Health and $6,576 at Hims & Hers — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Elevate Health · Hims & Hers. Official sites: Elevate Health ↗ · Hims & Hers ↗. Nothing here is medical advice.